| Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR | Eurosurveillance | 2020 | 4K |
| The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 | Nature Microbiology | 2020 | 3.8K |
| Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial | International Journal of Antimicrobial Agents | 2020 | 3K |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges | International Journal of Antimicrobial Agents | 2020 | 2.8K |
| Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China | Clinical Infectious Diseases | 2020 | 2.7K |
| Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus | Journal of Virology | 2020 | 2.6K |
| Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis | International Journal of Infectious Diseases | 2020 | 2.1K |
| Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents | Journal of Hospital Infection | 2020 | 1.9K |
| Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses | Nature Microbiology | 2020 | 1.8K |
| Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan | Emerging Microbes and Infections | 2020 | 1.7K |
| Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019 | Clinical Infectious Diseases | 2020 | 1.7K |
| Emerging coronaviruses: Genome structure, replication, and pathogenesis | Journal of Medical Virology | 2020 | 1.7K |
| In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Clinical Infectious Diseases | 2020 | 1.6K |
| Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle | Journal of Medical Virology | 2020 | 1.6K |
| The pathogenesis and treatment of the `Cytokine Storm' in COVID-19 | Journal of Infection | 2020 | 1.5K |
| Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020 | Eurosurveillance | 2020 | 1.4K |
| Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China | Cell Host and Microbe | 2020 | 1.3K |
| The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients | Journal of Medical Virology | 2020 | 1.3K |
| A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology | Nature Microbiology | 2020 | 1.3K |
| A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 | International Journal of Infectious Diseases | 2020 | 1.2K |
| Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure | Cell Host and Microbe | 2020 | 1.2K |
| Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes | Emerging Microbes and Infections | 2020 | 1.2K |
| The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro | Antiviral Research | 2020 | 1.1K |
| Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis | Journal of Infection | 2020 | 1.1K |
| Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality | International Journal of Antimicrobial Agents | 2020 | 1.1K |
